Literature DB >> 32294028

A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction.

Jennifer Gile1, Yoshimasa Oyama1, Sydney Shuff1, Tobias Eckle1.   

Abstract

BACKGROUND: We recently reported a role for the circadian rhythm protein Period 2 (PER2) in midazolam induced cognitive dysfunction. Based on previous studies showing a critical role for the adenosine A2B receptor (ADORA2B) in PER2 regulation, we hypothesized that hippocampal ADORA2B is crucial for cognitive function.
METHODS: Midazolam treated C57BL/6J mice were analyzed for Adora2b hippocampal mRNA expression levels, and spontaneous T-maze alternation was determined in Adora2b-/- mice. Using the specific ADORA2B agonist BAY-60-6583 in midazolam treated C57BL/6J mice, we analyzed hippocampal Per2 mRNA expression levels and spontaneous T-maze alternation. Finally, Adora2b-/- mice were assessed for mRNA expression of markers for inflammation or cognitive function in the hippocampus.
RESULTS: Midazolam treatment significantly downregulated Adora2b or Per2 mRNA in the hippocampus of C57BL/6J mice, and hippocampal PER2 protein expression or T-maze alternation was significantly reduced in Adora2b-/- mice. ADORA2B agonist BAY-60-6583 restored midazolam mediated reduction in spontaneous alternation in C57BL/6J mice. Analysis of hippocampal Tnf-α or Il-6 mRNA levels in Adora2b-/- mice did not reveal an inflammatory phenotype. However, C-fos, a critical component of hippocampus-dependent learning and memory, was significantly downregulated in the hippocampus of Adora2b-/- mice.
CONCLUSION: These results suggest a role of ADORA2B in midazolam induced cognitive dysfunction. Further, our data demonstrate that BAY-60-6583 treatment restores midazolam induced cognitive dysfunction, possibly via increases of Per2. Additional mechanistic studies hint towards C-FOS as another potential underlying mechanism of memory impairment in Adora2b-/- mice. These findings suggest the ADORA2B agonist as a potential therapy in patients with midazolam induced cognitive dysfunction. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Adora2b; BAY-60-6583; Bdnf; C-fos; Per2; T maze; cognitive function; delirium

Year:  2020        PMID: 32294028      PMCID: PMC7572481          DOI: 10.2174/1381612826666200415171622

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  68 in total

1.  GABA regulation of circadian responses to light. I. Involvement of GABAA-benzodiazepine and GABAB receptors.

Authors:  M R Ralph; M Menaker
Journal:  J Neurosci       Date:  1989-08       Impact factor: 6.167

Review 2.  Attenuating myocardial ischemia by targeting A2B adenosine receptors.

Authors:  Holger K Eltzschig; Stephanie K Bonney; Tobias Eckle
Journal:  Trends Mol Med       Date:  2013-03-26       Impact factor: 11.951

3.  ADORA2b Signaling in Cardioprotection.

Authors:  Jennifer Gile; Tobias Eckle
Journal:  J Nat Sci       Date:  2016

Review 4.  Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment.

Authors:  Carlos J Madrid-Navarro; Rosa Sanchez-Galvez; Antonio Martinez-Nicolas; Ros Marina; Jose A Garcia; Juan A Madrid; Maria A Rol
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  Differential Tissue-Specific Function of Adora2b in Cardioprotection.

Authors:  Seong-wook Seo; Michael Koeppen; Stephanie Bonney; Merit Gobel; Molly Thayer; Patrick N Harter; Katya Ravid; Holger K Eltzschig; Michel Mittelbronn; Lori Walker; Tobias Eckle
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

6.  Bright light therapy as an adjunctive treatment with risperidone in patients with delirium: a randomized, open, parallel group study.

Authors:  Jaewon Yang; Wonseok Choi; Young-Hoon Ko; Sook-Haeng Joe; Changsu Han; Yong-Ku Kim
Journal:  Gen Hosp Psychiatry       Date:  2012-06-18       Impact factor: 3.238

7.  Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia.

Authors:  Tobias Eckle; Katherine Hartmann; Stephanie Bonney; Susan Reithel; Michel Mittelbronn; Lori A Walker; Brian D Lowes; Jun Han; Christoph H Borchers; Peter M Buttrick; Douglas J Kominsky; Sean P Colgan; Holger K Eltzschig
Journal:  Nat Med       Date:  2012-04-15       Impact factor: 53.440

8.  Antibodies for assessing circadian clock proteins in the rodent suprachiasmatic nucleus.

Authors:  Joseph LeSauter; Christopher M Lambert; Margaret R Robotham; Zina Model; Rae Silver; David R Weaver
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memory.

Authors:  Jorge Valero; Giorgia Mastrella; Ismael Neiva; Silvia Sánchez; João O Malva
Journal:  Front Neurosci       Date:  2014-04-21       Impact factor: 4.677

10.  Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart.

Authors:  Stephanie Bonney; Doug Kominsky; Kelley Brodsky; Holger Eltzschig; Lori Walker; Tobias Eckle
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more
  2 in total

Review 1.  Do Sleep Disturbances have a Dual Effect on Alzheimer's Disease?

Authors:  Shirin Arjmandi-Rad; Mahshid Ebrahimnejad; Mohammad-Reza Zarrindast; Salar Vaseghi
Journal:  Cell Mol Neurobiol       Date:  2022-05-14       Impact factor: 5.046

2.  Activation of A2B adenosine receptor protects against demyelination in a mouse model of schizophrenia.

Authors:  Quanrui Ma; Dan Wang; Yunhong Li; Hao Yang; Yilu Li; Junyan Wang; Jinxia Li; Jinping Sun; Juan Liu
Journal:  Exp Ther Med       Date:  2022-04-14       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.